3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Neuroendocrine Tumors
70
Carcinoma, Neuroendocrine
7
Gastro-enteropancreatic neuroendocrine tumor
6
Carcinoid Tumor
6
Neoplasm Metastasis
5
Paraganglioma
3
Pancreatic Neoplasms
3
Carcinoma, Hepatocellular
3
Adenoma, Islet Cell
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Tertiary Lymphoid Structures
1
Teratoma
1
Small Intestinal Neuroendocrine Tumor
1
Small Cell Lung Carcinoma
1
Rectal Neuroendocrine Tumor
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Parkinson Disease
1
Pancreatic Neuroendocrine Tumors in MEN1
1
Osteomalacia
1
Neuroendocrine Tumors With Metastasis
1
Neuroendocrine Tumors Metastatic to the Liver
1
Neuroendocrine Tumor Grade 3
1
Neuroblastoma
1
Interventions
CTAP octapeptide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pancreatic Neuroendocrine Tumors in MEN1
×
NET
×
Clear all
NCT02705651
2019-04-08
SANO
Medical University of Vienna
Phase 3
Unknown
180 enrolled